[ad_1] For investors anxious about the market’s stretched valuation, Wells Fargo said there is no bubble forming. The S & P 500 is currently trading about 25 times forward earnings after a 27% rally, which makes today’s valuation seem expensive at first glance since the 30-year average price-to-earnings ratio is at 19 times, Wells Fargo said. However, the Wall Street firm argued that it might be unfair to compare to the historical average because the index is more efficient than ever. Wells Fargo pointed out that profit margins of S & P 500 companies have nearly doubled over the past…
Author: user
[ad_1] Investing.com — Shares of Humana Inc . (NYSE:) tumbled 6.5% as investors reacted to concerns regarding the company’s potential earnings exposure from its Humana Honor plans, which primarily serve veterans. A recent scenario analysis by analysts at Piper Sandler, inspired by a Wall Street Journal article, highlighted the earnings risks associated with members who are covered both by the Veterans Affairs (VA) and Medicare Advantage (MA). The analysis, which delved into Humana’s 375.7K Humana Honor plan members, suggested that while these plans were designed to attract veterans, they could represent a significant earnings risk in 2025. This comes at…
[ad_1] (Reuters) -Japanese auto giants Honda (NYSE:) Motor and Nissan (OTC:) Motor will start negotiations to merge as they face growing competition from bigger global electric vehicle makers, the newspaper reported on Tuesday. The two companies have increased ties in recent months as they face heavy competition from Chinese EV makers that has added pressure on legacy brands struggling to make enough profit from their EV ventures. Honda and Nissan were not immediately available for Reuters requests for comment. Reuters has not independently verified the Nikkei report. Nissan and Honda, Japan’s third and second biggest automakers after Toyota (NYSE:), have…
[ad_1] GreenIron and Scandinavian Steel AB, a leading metals distributor, have signed a collaboration agreement to deliver hydrogen DRI, a fossil-free iron product. [ad_2] Source link
[ad_1] Mark Cuban Calls Healthcare Pricing ‘Horrific’– Says Hospitals And Doctors Are ‘Sub Prime Lenders’ – But He’s Proposing A Way To Fix Things Mark Cuban isn’t holding back when it comes to his thoughts on the U.S. health care system. On Bluesky, on Dec. 10, he laid out exactly why he thinks the system is broken and how he’s taking steps to fix it. His biggest gripe? Hospitals and doctors are being forced into the role of “Sub Prime Lenders” because they bear 100% of the credit risk for unpaid deductibles, co-pays and coinsurance. “That’s insane,” he wrote, adding,…
[ad_1] Investing.com –Rosenblatt Securities initiated coverage of MongoDB (NASDAQ:) with a buy rating and a $350 price target, on strong growth opportunities in the database market and AI-driven applications. The brokerage sees MongoDB as a leading provider of NoSQL databases, set to benefit from the ongoing migration away from legacy systems. Rosenblatt analyst noted that recent weakness in MongoDB’s stock but views the current levels as attractive for long-term investors. “With the stock’s recent weakness on what we view as mostly misunderstandings,” analyst wrote. For Rubrik Inc (NYSE:), Rosenblatt started coverage with a neutral rating and a $77 price target.…
[ad_1] Investing.com — Honda (NYSE:) Motor and Nissan (OTC:) Motor are set to engage in discussions regarding a potential merger, aiming to pool resources to strengthen their position in the electric vehicle market, according to on Wednesday. The two Japanese automakers are contemplating the possibility of operating under a shared holding company, the report said, adding that a memorandum of understanding, which will formally initiate these negotiations, is expected to be signed shortly. Details regarding their respective stakes in the newly proposed entity, along with other specifics, will be determined at a later stage, the report said. This move signifies…
[ad_1] Sign up for free to read a limited number of articles each month.Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS NEWS Daily at 11:30 AM ET EARLY EDITION Daily at 7:15 AM ET ENDPOINTS PHARMA Daily at 3:30 PM ET BREAKING NEWS ALERTS 2-3 times a week ENDPOINTS FDA+ Wed at 2 PM ET ENDPOINTS MANUFACTURING Thu at 2 PM ET ENDPOINTS WEEKLY Sat at 6 AM ET POST-HOC 1-2 times a week Healthcare ENDPOINTS HEALTH TECH Tuesday, Thursday at 10 AM ET BREAKING NEWS ALERTS 2-3 times a week [ad_2] Source link
[ad_1] Investors are growing increasingly bullish as the stock market rally rolls on to end 2024. In Bank of America’s December Global Fund Manager Survey, 36% of respondents said they’re overweight US equities, the highest level seen in the survey’s history. This large shift into US stocks came alongside a record-low allocation to cash and a three-year high in global risk appetite. It also falls in line with recent calls across Wall Street for US “exceptionalism” to continue in 2025. Bank of America investment strategist Michael Hartnett noted that excitement about Donald Trump’s second-term, optimism surrounding growth in the US,…
[ad_1] By Jennifer Rigby LONDON (Reuters) – A new long-acting preventive HIV drug could reach the world’s poorest countries by the end of 2025 or early 2026, a global health official told Reuters on Tuesday. The ambition is to start deliveries of Gilead (NASDAQ:) Sciences’ lenacapavir on that timeline, said Hui Yang, head of supply operations at the Global Fund to Fight AIDS, Tuberculosis and Malaria. However, she said a lot of things need to happen first, including the injectable drug receiving regulatory approvals from authorities like the United States Food and Drug Administration and the World Health Organization. Lenacapavir…